Model: Female C57BL/6J mice aged 18 months Dosage: 3 micrograms of semaglutide injected every other day for two months
Approximately 70% of patients report experiencing food indifference by week 5
Dietary recommendations for the management of gastrointestinal symptoms in patients treated with GLP-1 receptor agonists
Department of Endocrinology and Metabolism, Kosin University Gospel Hospital, Kosin University College of Medicine, 262 Gamcheon-ro, Seo-gu, Busan 602-702, Korea
This does not include the cost of medication
While multiple clinical trials and population-based studies have established the safety profile of GLP-1RAs, continued vigilance regarding the association between GLP-1RA therapy and pancreatic cancer risk remains imperative in clinical practice, given the potential for low-grade chronic pancreatitis to induce pancreatic cancer